TRINO THERAPEUTICS
Trino is a drug discovery and early drug development company focused on anti-inflammatory therapeutics. The company is developing drug candidates from a novel, proprietary, class of drugs based on indane dimers derived from a Taiwanese fern. Its lead candidate is a potential first-in-class drug for the treatment of inflammatory bowel disease (IBD), which could be used in both ulcerative colitis (UC) and Crohn’s disease (CD). Trino’s drug class also offers promising candidates with a broad anti-inflammatory activity that could be suitable for applications in dermatology, pulmonary and auto-immune disease.
TRINO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1999-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.trinotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
353 1 670 9865
Email Addresses:
[email protected]
Total Funding:
9 M EUR
Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location
Similar Organizations
AlveoGene
AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Founder
Investors List
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Series A - Trino Therapeutics
Wellcome Trust
Wellcome Trust investment in Series A - Trino Therapeutics
Official Site Inspections
http://www.trinotherapeutics.com
- Host name: 160.124.254.132
- IP address: 160.124.254.132
- Location: South Africa
- Latitude: -29
- Longitude: 24
- Timezone: Africa/Johannesburg
